Boothbay Fund Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-66,000
Closed -$21.6M 2033
2025
Q4
$21.6M Buy
+66,000
New +$20.9M 0.32% 37
2022
Q3
Sell
-1,300
Closed -$316K 2217
2022
Q2
$316K Sell
1,300
-1,600
-55% -$392K 0.01% 1434
2022
Q1
$701K Buy
+2,900
New +$666K 0.02% 1117
2019
Q2
Sell
-397
Closed -$7.54M 721
2019
Q1
$7.54M Buy
+397
New +$75.8K 0.73% 20

Other funds holding AMGN

Boothbay Fund Management's AMGN Position: Q1 2026 in Review

Boothbay Fund Management reduced its Amgen (AMGN) stake by 88% in Q1 2026, selling an estimated $4.73M and leaving 1,755 shares worth $617K. The position accounts for 0.01% of the portfolio, ranked #1229.

Boothbay Fund Management first reported a position in AMGN in Q3 2015 and has held it in 15 quarters since. The position peaked at $4.92M in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Boothbay Fund Management held 1,755 shares of Amgen worth $617K as of Q1 2026.
  • Boothbay Fund Management sold 13,279 Amgen shares in Q1 2026, an estimated $4.73M.
  • Amgen made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1229 holding.
  • Boothbay Fund Management first reported a position in Amgen in Q3 2015 and has held it in 15 quarters since.
  • Boothbay Fund Management's Amgen position peaked at $4.92M in Q4 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.